Fluoxymesterone (Halotestin)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 00:30, 30 July 2023 by Jwarner (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Mechanism of action

Androgen and anabolic steroid

Diseases for which it was used

History of changes in FDA indication

  • 1956-10-15: Initial FDA approval

Also known as

  • Brand names: Halotestin, Ultandren
Retrieved from "https://hemonc.org/w/index.php?title=Fluoxymesterone_(Halotestin)&oldid=75940"